Schedule 13D ownership disclosure
LION BIOTECHNOLOGIES
Security class unavailable · CUSIP: 53619R102
Event date: 2016-06-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,778,947
- Percent of class
- 9.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-16-126891
- Form type
- SC 13D
- Filer
- IOVANCE BIOTHERAPEUTICS, INC.
- CIK
- CIK 1425205
- Filed
- Jun 13, 2016
- Reporting period
- Jun 02, 2016
- Description
- Schedule 13D beneficial ownership